Innospec Inc. (NASDAQ:IOSP) Holdings Decreased by Huber Capital Management LLC

Huber Capital Management LLC reduced its position in shares of Innospec Inc. (NASDAQ:IOSP) by 16.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 37,835 shares of the specialty chemicals company’s stock after selling 7,702 shares during the period. Huber Capital Management LLC owned about 0.15% of Innospec worth $4,676,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. TFO Wealth Partners LLC boosted its stake in Innospec by 29,800.0% in the fourth quarter. TFO Wealth Partners LLC now owns 299 shares of the specialty chemicals company’s stock valued at $37,000 after acquiring an additional 298 shares during the period. DekaBank Deutsche Girozentrale acquired a new position in Innospec during the 1st quarter valued at approximately $66,000. CWM LLC grew its stake in Innospec by 239.6% during the 2nd quarter. CWM LLC now owns 635 shares of the specialty chemicals company’s stock worth $78,000 after buying an additional 448 shares during the last quarter. Motco acquired a new stake in Innospec in the first quarter worth $132,000. Finally, EntryPoint Capital LLC bought a new stake in Innospec in the first quarter valued at $147,000. 96.64% of the stock is currently owned by institutional investors.

Innospec Trading Down 1.8 %

IOSP opened at $111.94 on Friday. Innospec Inc. has a twelve month low of $95.69 and a twelve month high of $133.71. The stock has a market cap of $2.79 billion, a PE ratio of 19.01 and a beta of 1.08. The business’s 50 day moving average is $115.79 and its 200-day moving average is $121.79.

Innospec (NASDAQ:IOSP) last released its quarterly earnings results on Tuesday, August 6th. The specialty chemicals company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.02. The company had revenue of $435.00 million during the quarter, compared to analysts’ expectations of $468.73 million. Innospec had a return on equity of 14.15% and a net margin of 7.90%. The company’s revenue for the quarter was down 9.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.28 earnings per share. As a group, analysts forecast that Innospec Inc. will post 5.95 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut shares of Innospec from a “strong-buy” rating to a “buy” rating in a report on Thursday, August 8th.

Insiders Place Their Bets

In other news, CFO Ian Cleminson sold 3,398 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $114.74, for a total value of $389,886.52. Following the completion of the transaction, the chief financial officer now directly owns 12,996 shares in the company, valued at $1,491,161.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.52% of the stock is owned by insiders.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.